Clinical Trial Update: Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating everolimus for progression of graft vascular disease in heart transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Fundacion Investigacion y Desarrollo | Conditions: Cardiac Transplant | Phase 4 | Status: UNKNOWN